These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 5808218)

  • 1. [Biochemical and clinical aspects of pyrophosphate metabolism. 3. Renal pyrhosphatase activity in patients with urinary calculi and healthy persons].
    Schneider HJ; Schulz M; Thielmann K
    Urol Int; 1969; 24(1):66-72. PubMed ID: 5808218
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical and clinical features of pyrophosphate metabolism. IV. Inhibition of human renal pyrophosphatase by inorganic orthophosphate in healthy persons and patients with calculi].
    Stachura G; Thielmann K; Schulze M; Schneider HJ
    Urol Int; 1970; 25(1):26-31. PubMed ID: 4317193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biochemical and clinical aspects of pyrophosphate metabolism. 2. Studies of the mechanism of enhanced pyrophosphate excretion in urine following orthophosphate loading].
    Thielmann K; Schulze M; Siegmund S; Hoeppener HH
    Acta Biol Med Ger; 1969; 22(5):687-98. PubMed ID: 4313445
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary angiotensin-I-converting enzyme activity as a marker of tubulo-interstitial involvement in kidney diseases.
    Baggio B; Piccoli A; Favaro S; Antonello A; Bertaglia E; Borsatti A
    Contrib Nephrol; 1989; 70():208-12. PubMed ID: 2569958
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action mechanism of orthophosphate in urinary calculi].
    Schneider HJ; Wasmund HG
    Z Urol Nephrol; 1971 May; 64(5):343-9. PubMed ID: 5142710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Renal clearance of lysozyme in various kidney diseases].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Carretta R
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1760-6. PubMed ID: 1231851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal clearance of malate dehydrogenase in various kidney diseases].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Carretta R
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1767-72. PubMed ID: 1231852
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Acid and alkaline urinary inorganic pyrophosphatase in the formation of calcium-containing urinary calculi.
    Eisenkraft C; Gaist L; Rubinstein J; Menache R
    Isr J Med Sci; 1975 Nov; 11(11):1226-7. PubMed ID: 1205831
    [No Abstract]   [Full Text] [Related]  

  • 9. [Urinary excretion of alpha-glucosidase in various kidney diseases].
    Campanacci L; Guarnieri GF; Faccini L; Bellini G; Carretta R
    Boll Soc Ital Biol Sper; 1975 Dec; 51(23):1773-8. PubMed ID: 1231853
    [No Abstract]   [Full Text] [Related]  

  • 10. [The enzyme function of cationic transmembrane transport and its relationship to the homeostatic indices of patients with chronic pyelonephritis].
    Tsvetsikh VE; Krylov VI; Lerner GIa; Kazeko NI; Ovchinnikov AA; Berdichevskiĭ BA; Sultanbaev RA; Lykov VN
    Urol Nefrol (Mosk); 1991; (1):48-50. PubMed ID: 1830430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic value of determination of urinary enzymes].
    Ceriotti G; Guarnieri GF
    Quad Sclavo Diagn; 1975 Mar; 11(1):103-21. PubMed ID: 1153694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical and clinical aspects of pyrophosphate metabolism. V. The activity of inorganic pyrophosphatase (E. C. 3.6.1.1) in human and rat kidney during varying orthophosphate uptake].
    Schulze M; Hörenz D; Rhinow B; Wasmund HG; Schneider HJ; Thielmann K
    Acta Biol Med Ger; 1972; 28(3):459-63. PubMed ID: 4114991
    [No Abstract]   [Full Text] [Related]  

  • 13. URINARY PYROPHOSPHATE AND UROLITHIASIS.
    RUSSELL RG; EDWARDS NA; HODGKINSON A
    Lancet; 1964 Jun; 2(7348):1446. PubMed ID: 14149185
    [No Abstract]   [Full Text] [Related]  

  • 14. [Characteristics of the clinical course and treatment of patients with urinary calculi of a solitary kidney].
    Sernjak PS; Safranow WJ
    Z Urol Nephrol; 1984 Feb; 77(2):101-6. PubMed ID: 6711154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphofructokinase activity in the serum and urine in patients with urolithiasis].
    Krikun AS
    Sov Med; 1977 Nov; (11):142-4. PubMed ID: 146918
    [No Abstract]   [Full Text] [Related]  

  • 16. [Two cases of 2.8-dihydroxyadenine stone with a partial deficiency of adenine phosphoribosyltransferase].
    Osawa O; Ohara T; Komatz Y
    Hinyokika Kiyo; 1991 Nov; 37(11):1535-8. PubMed ID: 1767776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspartate aminotransferase activities in renal tissue during experimental and human chronic pyelonephritis.
    Philippson C
    Exp Pathol (Jena); 1977; 13(6):328-37. PubMed ID: 923689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activity of proteolytic enzymes and trypsin inhibitor in blood serum and kidney in pyelonephritis].
    Levitsky AP; Grabazyuk
    Vopr Med Khim; 1975; 21(5):538-42. PubMed ID: 1216770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthogranulomatous pyelonephritis in a Malaysian population.
    Koh KB
    Singapore Med J; 1993 Aug; 34(4):341-2. PubMed ID: 8266209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various aspects of secondary pyelonephritis in urinary calculi].
    Stein G; Schneider HJ; Sperschneider H; Hensel K
    Z Urol Nephrol; 1978 May; 71(5):345-50. PubMed ID: 354267
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.